Institutional Ownership Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL). We have compiled data on the 113 institutions that hold shares in the stock, with a total of 175 Million shares, which have been reported (via 13F filing form) to have a value of $1.66 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Coldstream Capital Management Inc
|
May 13, 2025 Q1 2025 |
1,166
shares
|
$11,065
0.0% of portfolio
|
Q1 2025
New holding
|
|
Us Bancorp \De\
|
May 08, 2025 Q1 2025 |
1,165
shares
|
$11,055
0.0% of portfolio
|
Q1 2024
New holding
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
May 09, 2025 Q1 2025 |
1,018
shares
|
$9,660
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sargent Bickham Lagudis LLC
|
Jan 23, 2023 Q4 2022 |
1,000
shares
|
$9,490
0.0% of portfolio
|
Q4 2022
New holding
|
|
Simplex Trading, LLC
|
May 12, 2025 Q1 2025 |
990
shares
|
$9,395
0.0% of portfolio
|
Q1 2025
Added 60.45%
|
|
Daiwa Securities Group Inc.
Tokyo, M0 |
May 13, 2025 Q1 2025 |
917
shares
|
$8,702
0.0% of portfolio
|
Q2 2022
Added 30.63%
|
|
Nisa Investment Advisors, LLC
|
Apr 30, 2025 Q1 2025 |
500
shares
|
$4,745
0.0% of portfolio
|
Q1 2025
Reduced 27.01%
|
|
Ever Source Wealth Advisors, LLC
|
May 13, 2025 Q1 2025 |
106
shares
|
$1,005
0.0% of portfolio
|
Q1 2025
New holding
|
|
True Wealth Design, LLC
Akron, OH |
May 13, 2025 Q1 2025 |
60
shares
|
$569
0.0% of portfolio
|
Q1 2025
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|